ArticleThe journal of nutrition, health & aging2026
Accelerated biological aging, genetic susceptibility, and lifestyle in relation to abdominal aortic aneurysm: A prospective study.
Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to investigate the associations of biological age (BA) acceleration and genetic risk with the incidence of abdominal aortic aneurysm (AAA), and to evaluate the extent to which BA acceleration mediates the impact of a healthy lifestyle on AAA risk.
designA large prospective cohort study. SETTING AND
participantsThis study included 279,944 participants from the UK Biobank.
methodsTwo validated measures of BA, Klemera-Doubal Method Biological Age (KDM-BA) and PhenoAge, were estimated using clinical biomarkers. BA acceleration was calculated as the residual from regressing BA on chronological age. A polygenic risk score (PRS) was constructed based on AAA-associated genetic variants, and a healthy lifestyle score was derived from key behavioral factors. Cox proportional hazards models were used to assess the independent and joint associations of BA acceleration, PRS, and lifestyle score with AAA risk. Interaction and mediation analyses were also conducted.
resultsAmong the 279,944 participants, 1305 developed AAA over a mean follow-up of 15.5 years. Acceleration in both KDM-BA (HR, 1.89; 95% CI, 1.49-2.41) and PhenoAge (HR, 2.65; 95% CI, 2.21-3.17) was significantly positively associated with an increased risk of AAA. Significant interaction and joint effects were observed between genetic risk and BA acceleration. Compared with individuals with low genetic risk and low BA acceleration, those with both high PRS and high BA acceleration, particularly PhenoAge acceleration, had the highest risk of AAA (HR, 7.14; 95% CI, 5.64-8.46). Furthermore, a higher healthy lifestyle score was inversely associated with AAA risk, with approximately 7% of this association mediated through reduced BA acceleration.
conclusionsBoth BA acceleration and genetic predisposition were significant risk factors for AAA, highlighting their potential utility in guiding precision prevention strategies and targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.